Stop the Saatchi Bill

Driven by an extraordinary two-year PR campaign on social media and a supportive newspaper partner, this all started as Lord Saatchi’s Medical Innovation Bill, metamorphosed through several versions, and was resurrected under a new name by Chris Heaton-Harris, before finally clearing its last hurdle in the Lords this week to become the Access to Medical Treatments (Innovation) Act. Pretty much the only thing they share is the word 'Innovation' in the title.

One day, it may be possible for politicians to ask the people who actually work in the medical field: what are the problems you face, and how can we help you overcome them?

One day, politicians may actually listen to the answers they receive, and thus try to tackle genuine problems rather than imagined ones.

One day, politicians, medics, researchers, lawyers, patient groups, charities, and the public, may work together to overcome the barriers to the development and provision of new treatments.

But it is not this day.

Read more: Not this day

admin

When the facts change….

Re-blogged with permission from When the facts change…. by Nigel Poole QC Lord Saatchi may be seeking to re-introduce his Medical Innovation Bill unchanged, but the common law he blames for preventing a cure for cancer, has moved on. In January 2015 the House of Lords sent the Medical Innovation Bill to the Commons. The Bill sought to provide doctors with…

The HealthWatch UK debate on the Medical Innovation Bill

HealthWatch UK is a charity that has been promoting evidence-based healthcare since 1991. It has no connection with the Healthwatch organisations set up under the Health and Social Care Act 2012. They held a debate on 4 March 2015 in conjunction with King’s College London: “This house supports the Medical Innovation Bill”. For: Professor Sir Mike Rawlins, patron of HealthWatch UK…

A welcome decision

The Stop the Saatchi Bill Alliance welcomes the decision not to move the Medical Innovation Bill at its second reading. While we firmly support innovation, we were joined by countless charities, experts, professional and patients’ organisations in our concerns that the Bill, which was set to apply to all patients, all doctors, all conditions and all treatments, was both unnecessary…

The end of the Medical Innovation Bill

In just seven seconds, the fate of the Medical Innovation Bill was sealed: It was not moved by any MP. If it had been, it would have taken just one MP to shout ‘Object’ and it would have had to come back to the House of Commons for another attempt at a second reading. Because it was not moved, the…

The Medical Innovation Bill – In a Nutshell

Re-blogged with permission from The Medical Innovation Bill – In a Nutshell by Nigel Poole QC The Medical Innovation Bill has passed to the House of Commons from the House of Lords. The purpose of the bill is to promote responsible medical innovation. The means by which innovation is promoted in the bill is by seeking to reduce or remove the…

Into the Commons

The Medical Innovation Bill was sent to the House of Commons following its Third Reading in the House of Lords on 23 January 2015. The Third Reading followed the usual format for these debates: more politeness and deference but not very much real scrutiny and analysis. There were just two amendments proposed: one by Lords Winston and Saatchi and one by Lord Hunt…

Bil Arloesi Meddygol? Wales votes No

Re-blogged with permission from Bil Arloesi Meddygol? Wales votes No by Sofia The Welsh Assembly votes unanimously against Saatchi Bill Vote in the Senedd clear: National Assembly for Wales united against Saatchi Bill a solution in search of a problem and not a very sound solution at that Previous post on LCM here. The National Assembly for Wales debated the Medical…

The GMC: There is still no convincing argument

Re-blogged with permission from The GMC: There is still no convincing argument by Sofia The GMC tweeted a link yesterday highlighting its current position on the Medical Innovation Bill. This was a link to this month’s accountability hearing where the GMC provided oral evidence to the Health Committee in the House of Commons. At this hearing questions were asked about the…